Determination of physostigmine in plasma and cerebrospinal fluid by liquid chromatography with electrochemical detection.
Physostigmine (Phy) was determined in plasma and cerebrospinal fluid (CSF) by HPLC with electrochemical detection, with use of a normal-phase column and methanolic sodium acetate buffer, pH 4.6. The detection limit of the method was 0.5 micrograms/L for a 2-mL sample of plasma or 0.5 mL of CSF. Analytical recovery of Phy in the range from 0.5 to 40 micrograms/L was 60% (SD 5%) for plasma and 78% (SD 8%) for CSF. Excellent chromatographic separation of Phy without column deterioration during extended usage and constant recovery for a wide range of Phy concentrations makes the routine monitoring of plasma from patients with Alzheimer's disease economically feasible. Using our method, we measured Phy in 13 such patients' plasmas at 105 and 135 min after a 135-min intravenous infusion of 300, 600, and 900 micrograms of Phy per square meter of body surface. Mean values significantly increased with dose (P = 0.001), but differences between 105 and 135 min (P = 0.229) or between dose and time (P = 0.949) were not significant.
Unni
L K
LK
Department of Psychiatry, Southern Illinois University School of Medicine, Springfield 62794-9230.
Hannant
M E
ME
Becker
R E
RE
Giacobini
E
E
D000544:Alzheimer Disease / Q000188:drug therapy; D002851:Chromatography, High Pressure Liquid / Q000379:methods; D004563:Electrochemistry; D006801:Humans; D007262:Infusions, Intravenous; D010830:Physostigmine / Q000008:administration & dosage / Q000032:analysis* / Q000097:blood / Q000134:cerebrospinal fluid
D010830:Physostigmine